4//SEC Filing
STAHL NEIL 4
Accession 0001968202-24-000115
CIK 0000872589other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:05 PM ET
Size
16.9 KB
Accession
0001968202-24-000115
Insider Transaction Report
Form 4
STAHL NEIL
SVP Res and Dev Sciences
Transactions
- Sale
Common Stock
2024-08-08$1082.69/sh−200$216,538→ 55,896 total - Sale
Common Stock
2024-08-08$1083.76/sh−1,006$1,090,263→ 54,890 total - Sale
Common Stock
2024-08-08$1084.61/sh−1,883$2,042,321→ 53,007 total - Sale
Common Stock
2024-08-08$1085.01/sh−1,708$1,853,197→ 51,299 total - Sale
Common Stock
2024-08-08$1081.83/sh−100$108,183→ 56,096 total - Sale
Common Stock
2024-08-08$1086.15/sh−300$325,845→ 50,999 total - Gift
Common Stock
2024-08-12−900→ 50,099 total
Holdings
- 5,849(indirect: By 401(k))
Common Stock
- 4,605(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]Represents volume-weighted average price of sales of 100 shares of Company stock on August 8, 2024 at prices ranging from $1,081.75 to $1,081.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
- [F2]Represents volume-weighted average price of sales of 200 shares of Company stock on August 8, 2024 at prices ranging from $1,082.65 to $1,082.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 1,006 shares of Company stock on August 8, 2024 at prices ranging from $1,083.27 to $1,083.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 1,883 shares of Company stock on August 8, 2024 at prices ranging from $1,084.01 to $1,084.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 1,708 shares of Company stock on August 8, 2024 at prices ranging from $1,085.00 to $1,085.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
- [F6]Represents volume-weighted average price of sales of 300 shares of Company stock on August 8, 2024 at prices ranging from $1,086.14 to $1,086.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001226689
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:05 PM ET
- Size
- 16.9 KB